Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-09

Clinical Trial Update: Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating the impact of exenatide on cardiovascular exercise performance in individuals with Type 2 diabetes; results posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2018-07-09